KR20150028245A - 고리형 매크로라이드계 화합물의 분리 방법 - Google Patents

고리형 매크로라이드계 화합물의 분리 방법 Download PDF

Info

Publication number
KR20150028245A
KR20150028245A KR1020147035002A KR20147035002A KR20150028245A KR 20150028245 A KR20150028245 A KR 20150028245A KR 1020147035002 A KR1020147035002 A KR 1020147035002A KR 20147035002 A KR20147035002 A KR 20147035002A KR 20150028245 A KR20150028245 A KR 20150028245A
Authority
KR
South Korea
Prior art keywords
compound
tacrolimus
silica gel
cyclic macrolide
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020147035002A
Other languages
English (en)
Korean (ko)
Inventor
유야 츠쿠다
게이타 무라마츠
히로노리 사사키
히로히데 나카무라
Original Assignee
고도 슈세이 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고도 슈세이 가부시키가이샤 filed Critical 고도 슈세이 가부시키가이샤
Publication of KR20150028245A publication Critical patent/KR20150028245A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3833—Chiral chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/29—Chiral phases
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
    • B01J20/3204—Inorganic carriers, supports or substrates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3268—Macromolecular compounds
    • B01J20/328—Polymers on the carrier being further modified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2253/00—Adsorbents used in seperation treatment of gases and vapours
    • B01D2253/10—Inorganic adsorbents
    • B01D2253/106—Silica or silicates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/884—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020147035002A 2012-07-06 2013-07-05 고리형 매크로라이드계 화합물의 분리 방법 Ceased KR20150028245A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2012-152913 2012-07-06
JP2012152913 2012-07-06
PCT/JP2013/068466 WO2014007362A1 (ja) 2012-07-06 2013-07-05 環状マクロライド系化合物の分離方法

Publications (1)

Publication Number Publication Date
KR20150028245A true KR20150028245A (ko) 2015-03-13

Family

ID=49882113

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147035002A Ceased KR20150028245A (ko) 2012-07-06 2013-07-05 고리형 매크로라이드계 화합물의 분리 방법

Country Status (9)

Country Link
EP (1) EP2871188B1 (https=)
JP (1) JP6210983B2 (https=)
KR (1) KR20150028245A (https=)
CN (1) CN104428308B (https=)
ES (1) ES2624229T3 (https=)
HU (1) HUE032954T2 (https=)
IN (1) IN2014DN11183A (https=)
TW (1) TWI614255B (https=)
WO (1) WO2014007362A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109406650A (zh) * 2018-10-25 2019-03-01 美康生物科技股份有限公司 用于准确测定人全血中四种免疫抑制剂类药物浓度的试剂盒及检测方法
CN114516884B (zh) * 2022-01-05 2024-03-19 福建省微生物研究所 一种高纯度他克莫司的提纯方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR901156A (fr) 1943-01-19 1945-07-19 Degussa Procédé pour la fabrication de matières artificielles
FR900525A (fr) 1943-12-13 1945-07-02 Réchaud, notamment pour le plein air
GB8430455D0 (en) 1984-12-03 1985-01-09 Fujisawa Pharmaceutical Co Fr-900506 substance
DK1064942T3 (da) * 1998-03-26 2004-11-01 Fujisawa Pharmaceutical Co Sustained release-fremstilling af et makrolid
CN1154651C (zh) * 1999-05-25 2004-06-23 藤泽药品工业株式会社 分离类似的有机化合物的方法
TW553946B (en) 1999-09-08 2003-09-21 Fujisawa Pharmaceutical Co Method for separating lactone-containing high-molecular weight compounds
US6825172B2 (en) * 2002-05-31 2004-11-30 Janssen Pharmaceutica, Nv 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents
CN1856500A (zh) * 2003-07-24 2006-11-01 特瓦药厂私人有限公司 纯化大环内酯类化合物的方法
CA2552305A1 (en) * 2003-12-30 2005-07-14 Astellas Pharma Inc. Use of macrolides for treating or preventing airflow obstruction
JP4515812B2 (ja) * 2004-04-28 2010-08-04 ダイセル化学工業株式会社 光学異性体用分離剤
CN101087796A (zh) * 2004-12-22 2007-12-12 特瓦药厂私人有限公司 纯化他克莫司的方法
CN101712685B (zh) * 2009-06-22 2012-07-04 鲁南制药集团股份有限公司 一种他克莫司粗品的精制方法

Also Published As

Publication number Publication date
CN104428308A (zh) 2015-03-18
TW201410682A (zh) 2014-03-16
CN104428308B (zh) 2016-11-09
HUE032954T2 (hu) 2017-11-28
WO2014007362A1 (ja) 2014-01-09
EP2871188A4 (en) 2015-12-02
TWI614255B (zh) 2018-02-11
JPWO2014007362A1 (ja) 2016-06-02
ES2624229T3 (es) 2017-07-13
EP2871188B1 (en) 2017-04-19
EP2871188A1 (en) 2015-05-13
IN2014DN11183A (https=) 2015-10-02
JP6210983B2 (ja) 2017-10-11

Similar Documents

Publication Publication Date Title
RU2234509C2 (ru) Способ разделения подобных органических соединений
CN1195760C (zh) 含内酯的高分子量化合物的分离方法
KR20030036793A (ko) 광학활성인(3알,5에스,6이)-7-[2-시클로프로필-4-(4-플루오르페닐)퀴놀린-3-일]-3,5-디히드록시-6-헵텐산 에틸의제조방법
KR20150028245A (ko) 고리형 매크로라이드계 화합물의 분리 방법
CN107118116A (zh) 一种利用大孔吸附树脂分离纯化5‑氨基戊酸的方法
JP6650630B2 (ja) エルゴステロール修飾担体、抗真菌剤の候補物質のスクリーニング方法、及び抗真菌剤の原料の精製方法
JP5532337B2 (ja) 発酵培地に担体として作用する固体吸着樹脂の提供によるトリシクロ化合物の生産及び抽出方法
CN107192785B (zh) 放线菌jy-22抗真菌成分分离方法及其在复配剂中的应用
Timofeeva et al. Isolation of an A-1149 Antibiotic Complex from Producing Strain Culture Broth using Amberlite XAD-2 and Ultradispersed Carbon Sorbent (UDUS)
CN107589189B (zh) 一种氟甲喹的手性对映体的检测方法
JP2006288303A (ja) リボフラビン配糖体の精製方法および分析方法
CN107903277B (zh) 一种n-甲基-美达霉素类化合物及其制备方法和应用
JPH0317095A (ja) ビタミンｂ↓１↓２およびその誘導体の分離回収方法
RU2545315C2 (ru) Способ получения хиральной планарной пластины для тонкослойной хроматографии оптических изомеров
Wang et al. Identification and separation of the novel antifungal antibiotic of streptomyces hygroscopicus BOS-013 strain by Simulated Moving Bed Chromatography
EP1637542A1 (en) Separatory agent for optical isomer
KR20020071638A (ko) Ｈｐ20 수지 및 에탄올을 이용한 프라바스타틴의 정제방법
Timofeeva et al. Use of ultradispersed carbon sorbent (UDUS) for the extraction of A-887 antibiotic (actinomycin D) from culture broth of producing strain
Zhang et al. A novel endotoxin adsorbent with branch ligand
WO2020162442A1 (ja) サーモスポロスリックス・ハザケンシス（Ｔｈｅｒｍｏｓｐｏｒｏｔｈｒｉｘ ｈａｚａｋｅｎｓｉｓ）由来の抗菌活性物質
EP1765802A1 (en) Process for the isolation of paclitaxel
HK1048991B (en) Method for separating lactone-containing high-molecular weight compounds
KR20020071637A (ko) 메탄올을 이용한 프라바스타틴의 정제방법
KR20040028303A (ko) 의사(擬似)이동마루식 크로마토그래피에 의한 광학 분할에있어서의 광학 이성체와 용매와의 회수 방법 및 용매의순환 사용 방법
KR20020071639A (ko) Ｈｐ20 수지 및 아세톤을 이용한 프라바스타틴의 정제방법

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20141212

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20180430

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20190627

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20190830

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20190627

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I